Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Research Article Volume 6 Issue 4

Epidemiological Profile of Glomerular Nephropathies in the Oran Region West Algeria

F Zerdoumi1*, M Medjamia1, S Boudani1 and K Djoudad1

1Department of Nephrology Hemodialysis Renal Transplantation, Faculty of Medicine Oran, University I. Research Project N ° D00L04UN31012019002, Algeria
2Anatomical Pathology Department, Faculty of Medicine Oran, University I. Research Project N ° D00L04UN31012019002, Algeria

*Corresponding Author: F Zerdoumi, Department of Nephrology Hemodialysis Renal Transplantation, Faculty of Medicine Oran, University I. Research Project N ° D00L04UN31012019002, Algeria.

Received: December 29, 2021; Published: March 16, 2022


Introduction: Early identification of kidney disease is an essential step in optimizing management. To this end, we present to you the anatomo-clinical description of the main nephropathies of our department during the interval from 01.09.2017 to 28.02.2021.

Material and Methods: 180 renal biopsies were performed during this interval. Our study is prospective and descriptive. It relates to the study of the frequency, and the anatomo-clinical specificity of nephropathies. Any adult patient over 16 years old with kidney disease was included in the study; descriptive analysis was done by Microsoft Excel2010.

Results: Average age 33.94 ± 15.06 years with overall male to female ratio 1.12. Among primary nephropathies, lipoid nephrosis dominates (33.33% including 25% MCD and 8.33% FSGS) followed by MGN (10%), IgA nephropathy (5.55%), DPGN (2.77%), Crescentic GN (2.21%), CIN (2.22%) and AIN (1.6%). For secondary nephropathies, lupus nephropathy dominates (20%) followed by AA amyloidosis (3.33%). Nephrotic syndrome (74%) represents the most frequent reason for renal biopsy. Histologically, with regard to the low chronicity index compared to 00 globally sclerotic glomeruli (75%) and absence of interstitial fibrosis (77%).

Discussion and Conclusion: In comparison with the data from the African Registry of the main glomerular nephropathies (Plos one 2016; 11 (5); e0152203), the Nephrotic syndrome remains the main reason for renal biopsy and the transition observed in Tunisia [1] (little amyloidosis and DPGN) matches our results with however a predominance of lipoid nephrosis.

Keywords: Crescentic; Glomerular Nephropathies; Algeria


  1. Ben Maiz H., et al. “Epidemiology of glomerular diseases in Tunisia from 1975-2005. Influence of changes in healthcare and society”. Bulletin de l'Académie nationale de médecine2 (2006): 403-416.
  2. GBD CKD collaboration. “Global, regional, and national of CKD, 1990-2017 a systematic analysis for the global burden of disease study 2017”. Lancet10225 (2020): 709-733.
  3. Katia Berkouche., et al. “ESRKD in Sidi Bel Abbes, Algeria: Epidemiological profile of hemodialysis patients from 2015 to 2018”. Clinical Epidemiology and Global Health V12 (2021) 100808.
  4. F Zerdoumi., et al. “Delayed orientation in Nephrology, about the experience of EHU Oran”. 18th Congress of the Society Algérienne d’HTA 09.10. (2021).
  5. Ikechi G Okpechi., et al. “Epidemiology of histologically proven glomerulonephritis in Africa. A systematic review and meta analysis”. Plos One3 (2016): e0152203.
  6. Giliane Nanchen., et al. “Incidences of glomerulonephritis in the western part of Switzerland over the last decade”. Swiss Medical Weekly 150 (2020): w20353.
  7. Steward JH., et al. “ESRD incidence group study”. Geographic, ethnic, age-related and temporal variation in the incidence of end stage renal disease in Europe, Canada, and Asia Pacific region 1998-2002. NDT 21.8 (2006): 2178-2183.
  8. Center for disease control and prevention - Chronic kidney diseases surveillance system website (2021).
  9. Sim JJ., et al. “ESRD and mortality outcomes across different glomerulonephropathies in a large diverse US population”. Mayo Clinic Proceedings 2 (2018): 167-178.


Citation: F Zerdoumi., et al. “Epidemiological Profile of Glomerular Nephropathies in the Oran Region West Algeria”.Acta Scientific Medical Sciences 6.4 (2022): 115-118.


Copyright: © 2022 F Zerdoumi., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US